Bausch + Lomb: Character Biosciences Secures $93 Million to Advance Genetics-Based Therapeutics for AMD
Character Biosciences announced the completion of an oversubscribed $93 million Series B financing round, which will be used to accelerate the de
Read full article »
Bausch and Lomb is a New Jersey-based medical device company that manufactures and supplies ophthalmic products and accessories for the healthcare industry.
Read more